A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

The FDA has approved a prefilled syringe formulation of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) that allows patients to self-inject the medication.

Recent research published by JAMA Network Open found that primary care physicians commonly worked in the EHR during their vacations.